HelanderEM.WebbMP.BiasMet al. A comparison of multimodal analgesic approaches in institutional enhanced recovery after surgery protocols for colorectal surgery: pharmacological agents. J Laparoendosc Adv Surg Tech A. 2017;27(9):903-908.doi:10.1089/lap.2017.0338http://www.ncbi.nlm.nih.gov/pubmed/28742427
2.
GorfineS.OnelE.PatouG.KrivokapicZ. Extended pain relief trial utilizing infiltration of Exparel(®), a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open colectomyBupivacaine Extended-Release Liposome Injection for Prolonged Postsurgical Analgesia in Patients Undergoing Hemorrhoidectomy: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Diseases of the Colon & Rectum. 2011;54(12):1552-1559.doi:10.2147/JPR.S38621http://www.ncbi.nlm.nih.gov/pubmed/23204866
3.
MarcetJE.NfonsamVN.LarachS. An extended paIn relief trial utilizing the infiltration of a long-acting multivesicular liposome formulation of bupivacaine, EXPAREL® (improve): a phase IV health economic trial in adult patients undergoing ileostomy reversal. J Pain Res. 2013;6:549-555.doi:10.2147/JPR.S46467http://www.ncbi.nlm.nih.gov/pubmed/23901290
4.
CohenSM. Extended pain relief trial utilizing infiltration of EXPAREL®, a long-acting multivesicular liposome formulation of bupivacaine: a phase IV health economic trial in adult patients undergoing open colectomy. J Pain Res. 2012;5:567-572.doi:10.2147/JPR.S38621http://www.ncbi.nlm.nih.gov/pubmed/23204866
